To assess the efficacy and safety of antiplatelet and anticoagulant agents for preventing the recurrence of any peripheral vascular thrombosis (arterial or venous, or both) in patients with Antiphospholipid syndrome.
This is a protocol.
To assess the efficacy and safety of antiplatelet and anticoagulant agents for preventing the recurrence of any peripheral vascular thrombosis (arterial or venous, or both) in patients with Antiphospholipid syndrome.
This is a protocol.